There is an increasing interest in medicinal plants to find natural remedies relatively safer than synthetic alternatives. The present study reports the evaluation of the in vitro and in vivo biological properties of crude extract (CrE), hexane (HeE), ethyl acetate (EAE) and aqueous (AqE) fractions of Aristolochia clematitis. The polyphenol and flavonoid content were determined and varied from 15.77 ± 0.28 to 93.62 ± 1.63 mg EGA/g, and 5.71 ± 0.1 to 13.53 ± 0.15 µg EQ/mg, respectively. Crude extract (CrE) and ethyl acetate (EaE) showed the highest scavenging activity of DPPH radicals (IC50 = 50.66 ± 1.41 and 69.57 ± 0.38 µg/mL) and hydroxyl radicals (IC50 = 0.894 ± 0.042 and 0.905 ± 0.890 mg/mL), reducing power (113.85 ± 0.5 and 82.45 ± 0.13 mg/mL) and the ability to inhibit β-carotene oxidation (76.13 ± 0.93, 69.18 ± .95 %). All extracts have the ability to protect red blood cells from AAPH peroxyl radicals and significantly increase hemolysis time compared to vitamin C. Tested on normal human plasma at a concentration of 50 and 100 mg/mL, these extract prolonged prothrombin (PT) and partial thromboplastin (aPTT) times. In addition, CrE tested at doses of 150 and 300 mg/kg, showedpotent antinociceptive effect (40.68 ± 3.84 and 66.61 ± 4.71%) and anti-inflammatory activity (65.71 ± 1.41 and 63.89 ± 2.17%). The results support the use of this plant in traditional medicine and suggest that it may contain phytochemicals that have the potential to be active agents as antioxidants, anticoagulants and analgesics.